Sökning: onr:"swepub:oai:gup.ub.gu.se/220153" >
Clinical outcomes a...
Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF)
-
Cannon, J. A. (författare)
-
Collier, T. J. (författare)
-
Shen, L. (författare)
-
visa fler...
-
- Swedberg, Karl, 1944 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
-
Krum, H. (författare)
-
van Veldhuisen, D. J. (författare)
-
Vincent, J. (författare)
-
Pocock, S. J. (författare)
-
Pitt, B. (författare)
-
Zannad, F. (författare)
-
McMurray, J. J. V. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2015-07-03
- 2015
- Engelska.
-
Ingår i: European Journal of Heart Failure. - : Wiley. - 1388-9842. ; 17:7, s. 707-716
- Relaterad länk:
-
https://onlinelibrar...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- AimsWe examined the relationship between different degrees of QRS prolongation and different QRS morphologies and clinical outcomes in patients with heart failure, reduced ejection fraction (HF-REF), and mild symptoms in the Eplerenone in Mild Patients Hospitalization and SurvIval Study in Heart Failure trial (EMPHASIS-HF). We also evaluated the effect of eplerenone in these patients according to QRS duration/morphology. Methods and resultsPatients were categorized as: QRS duration (ms) (i) <120 (n = 1375); (ii) 120-149 (n = 517); and (iii) 150 (n = 383), and QRS morphology (i) normal (n = 1252); (ii) left bundle branch block (BBB) (n = 608); and (iii) right BBB/intraventricular conduction defect (IVCD) (n = 415). The outcomes examined were the composite of cardiovascular death or heart failure hospitalization and all-cause mortality. Both abnormal QRS duration and QRS morphology were associated with higher risk, e.g. the rates of the composite outcome were: 10.2, 17.6, and 15.5 per 100 patient-years in the <120, 120-149, and 150ms groups, respectively. Eplerenone reduced the risk of the primary outcome and mortality, compared with placebo, consistently across the QRS duration/morphology subgroups. ConclusionWe found that even moderate prolongation of QRS duration and right BBB/IVCD were associated with a high risk of adverse outcomes in HF-REF. Eplerenone was similarly effective, irrespective of QRS duration/morphology.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Systolic heart failure
- Clinical trial
- Eplerenone
- CARDIAC-RESYNCHRONIZATION-THERAPY
- BUNDLE-BRANCH BLOCK
- TASK-FORCE
- MORTALITY
- IMPACT
- METAANALYSIS
- PREVALENCE
- GUIDELINES
- MORBIDITY
- BENEFIT
- Cardiac & Cardiovascular Systems
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Cannon, J. A.
-
Collier, T. J.
-
Shen, L.
-
Swedberg, Karl, ...
-
Krum, H.
-
van Veldhuisen, ...
-
visa fler...
-
Vincent, J.
-
Pocock, S. J.
-
Pitt, B.
-
Zannad, F.
-
McMurray, J. J. ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
European Journal ...
- Av lärosätet
-
Göteborgs universitet